Group II metabotropic glutamate receptors (mGluRs) comprise mGluR2 (mGlu2; encoded by GRM2) and mGluR3 (mGlu3; encoded by GRM3) and modulate glutamate neurotransmission and synaptic plasticity. Here we review the expression and function of mGluR3 and its involvement in schizophrenia. mGluR3 is expressed by glia and neurons in many brain regions and has a predominantly presynaptic distribution, consistent with its role as an inhibitory autoreceptor and heteroceptor. mGluR3 splice variants exist in human brain but are of unknown function. Differentiation of mGluR3 from mGluR2 has been problematic because of the lack of selective ligands and antibodies; the available data suggest particular roles for mGluR3 in long-term depression, in glial function and in neuroprotection. Some but not all studies find genetic association of GRM3 polymorphisms with psychosis, with the risk alleles also being associated with schizophrenia-related endophenotypes such as impaired cognition, cortical activation and glutamate markers. The dimeric form of mGluR3 may be reduced in the brain in schizophrenia. Finally, preclinical findings have made mGluR3 a putative therapeutic target, and now direct evidence for antipsychotic efficacy of a group II mGluR agonist has emerged from a randomised clinical trial in schizophrenia. Together these data implicate mGluR3 in aetiological, pathophysiological and pharmacotherapeutic aspects of the disorder.
Anwyl, R. (1999) Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Rev29: 83-120.
2.
Aronica, E., Gorter, JA, Ijlst-Keizers, H., Rozemuller, AJ, Yankaya, B., Leenstra, S., Troost, D. (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci17: 2106-2118.
3.
Aultman, JM, Moghaddam, B. (2001) Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacology153: 353-364.
4.
Baker, DA, Xi, ZX, Shen, H., Swanson, CJ, Kalivas, PW (2002) The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci22: 9134-9141.
5.
Berent-Spillson, A., Robinson, AM, Golovoy, D., Slusher, B., Rojas, C., Russell, JW (2004) Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. J Neurochem89: 90-99.
6.
Berthele, A., Platzer, S., Laurie, DJ, Weis, S., Sommer, B., Zieglgansberger, W., Conrad, B., Tolle, TR (1999) Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum. Neuroreport10: 3861-3867.
7.
Bishop, JR, Ellingrod, VL, Moline, J., Miller, D. (2005) Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr Res77: 253-260.
8.
Blumcke, I., Behle, K., Malitschek, B., Kuhn, R., Knopfel, T., Wolf, HK, Wiestler, OD (1996) Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus. Brain Res736: 217-226.
9.
Bruno, V., Battaglia, G., Casabona, G., Copani, A., Caciagli, F., Nicoletti, F. (1998a) Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci18: 9594-9600.
10.
Bruno, V., Molinaro, G., Battaglia, G., Nicoletti, F., Corti, C. (2005) The group-II mGlu receptor agonist, LY379268, differentially affects neuronal vulnerability in mGlu2 and mGlu3 receptor knockout mice. Neuropharmacology49: 235-236.
11.
Bruno, V., Wroblewska, B., Wroblewski, JT, Fiore, L., Nicoletti, F. (1998b) Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Neuroscience85: 751-757.
12.
Bulenger, S., Marullo, S., Bouvier, M. (2005) Emerging role of homo-and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci26: 131-137.
13.
Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., Carlsson, ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol41: 237-260.
14.
Carter, K., Dickerson, J., Schoepp, DD, Reilly, M., Herring, N., Williams, J., Sallee, FR, Sharp, JW, Sharp, FR (2004) The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis . Neuropharmacology47: 1135-1145.
15.
Cartmell, J., Monn, JA, Schoepp, DD (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther291: 161-170.
16.
Cartmell, J., Monn, JA, Schoepp, DD (2000a) Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268. Naunyn-Schmiedeberg's Arch Pharmacol361: 39-46.
17.
Cartmell, J., Monn, JA, Schoepp, DD (2000b) Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine. Psychopharmacology148: 423-429.
18.
Cartmell, J., Schoepp, DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem75: 889-907.
19.
Catania, MV, Landwehrmeyer, GB, Testa, CM, Standaert, DG, Penney, JB, Young, AB (1994) Metabotropic glutamate receptors are differentially regulated during development. Neuroscience61: 481-495.
20.
Chaki, S., Yoshikawa, R., Okuyama, S. (2006) Group II metabotropic glutamate receptor-mediated regulation of dopamine release from slices of rat nucleus accumbens. Neurosci Lett404: 182-186.
21.
Chavez-Noriega, LE, Schaffhauser, H., Campbell, UC (2002) Metabotropic glutamate receptors: potential drug targets for the treatment of schizophrenia. Current Drug Targets-CNS Neurol Disord1: 261-281.
22.
Chen, Q., He, G., Chen, QY, Wu, SN, Xu, YF, Feng, GY, Li, YC, Wang, LJ, He, L. (2005) A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res73: 21-26.
23.
Ciccarelli, R., Sureda, FX, Casabona, G., Di Iorio, P., Caruso, A., Spinella, F., Condorelli, DF, Nicoletti, F., Caciagli, F. (1997) Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture. Glia21: 390- 398.
24.
Collier, DA, Li, T. (2003) The genetics of schizophrenia: glutamate not dopamine ? Eur J Pharmacol480: 177-184.
25.
Conn, PJ, Pin, JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol37: 205-237.
26.
Corti, C., Andreoli, M., Marcon, C., Zambon, S., Heidbreder, CA, Mugnaini, M. (2004) Generation and characterization of mGluR3 deficient mice in models of alcohol dependence. Soc Neurosci2004 (Abstract Viewer Program No. 234.15).
27.
Corti, C., Battaglia, G., Molinaro, G., Riozzi, B., Pittaluga, A., Corsi, M., Mugniani, M., Nicoletti, F., Bruno, V. (2007a) The use of knockout mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodgeneration/neuroprotection . J Neurosci27: 8297-8308.
28.
Corti, C., Crepaldi, L., Mion, S., Roth, AL, Xuereb, JH, Ferraguti, F. (2007b) Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia. Biol Psychiatry62: 747-755.
29.
Corti, C., Sala, CF, Yang, FT, Corsi, M., Xuereb, JH, Ferraguti, F. (2000) Genomic organization of the human metabotropic glutamate receptor subtype 3. J Neurogenet14: 207-211.
30.
Corti, C., Xuereb, JH, Corsi, M., Ferraguti, F. (2001) Identification and characterization of the promoter region of the GRM3 gene. Biochem Biophys Res Comm286: 381-387.
31.
Crook, JM, Akil, M., Law, BCW, Hyde, TM, Kleinman, JE (2002) Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects. Mol Psychiatry7: 157-164
32.
David, HN, Abraini, JH (2003) Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. Neuropharmacology44: 717-727.
33.
De Blasi, A., Conn, PJ, Pin, JP, Nicoletti, F. (2001) Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci22: 114-120.
34.
De Quervain, DJF, Papassotiropoulos, A. (2006) Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. Proc Natl Acad Sci USA103: 4270-4274.
35.
Dunayevich, E., Erickson, J., Levine, L., Landbloom, R., Scheopp, DD, Tollefson, GD (2007) Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder. Neuropsychopharmacology (advance online publication, 22 August 2007; doi:10.1038/sj.npp.1301531).
36.
Egan, MF, Goldberg, TE, Kolachana, BS, Callicott, JH, Mazzanti, CM, Straub, RE, Goldman, D., Weinberger, DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA98: 6917-6922.
37.
Egan, MF, Straub, RE, Goldberg, TE, Yakub, I., Callicott, JH, Hariri, AR, Mattay, VS, Bertolino, A., Hyde, TM, Shannon-Weickert, C., Akil, M., Crook, J., Vakkalanka, RK, Balkissoon, R., Gibbs, RA, Kleinman, JE, Weinberger, DR (2004) Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA101: 12604-12609.
38.
Enz, R. (2006) The trick of the tail: protein-protein interactions of metabotropic glutamate receptors. BioEssays29: 6-73.
39.
Fallin, MD, Lasseter, VK, Avramopoulos, D., Nicodemus, KK, Wolyniec, PS, McGrath, JA, Steel, G., Nestadt, G., Liang, KY, Huganir, RL, Valle, D., Pulver, AE (2005) Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet77: 918-936.
Flajolet, M., Rakhilin, S., Wang, H., Starkova, N., Nuangchamnong, N., Nairn, AC, Greengard, P. (2003) Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3. Proc Natl Acad Sci USA100: 16006-16011.
42.
Fotuhi, M., Standaert, DG, Testa, CM, Penney, JB, Young, AB (1994) Differential expression of metabotropic glutamate receptors in the hippocampus and entorhinal cortex of the rat. Mol Brain Res21: 283-292.
43.
Fujii, Y., Shibata, H., Kikuta, R., Makina, C., Tani, A., Hirata, N., Shibata, A., Ninomiya, H., Tashiro, N., Fukumaki, Y. (2003) Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet13: 71-76.
44.
Galici, R., Jones, CK, Hemstapat, K., Nong, Y., Echemendia, NG, Williams, LC, de Paulis, T., Conn, PJ (2006) Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice. J Pharmacol Exp Ther318: 173-185.
Gray, JA, Roth, BL (2007) The pipeline and future of drug development in schizophrenia. Mol Psychiatry12: 904-922.
47.
Greco, B., Invernizzi, RW, Carli, M. (2005) Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2/3) receptor agonist LY379268. Psychopharmacology179: 68-76.
48.
Green, E., Grozeva, D., Norton, N., Jones, I., Jones, L., O'Donovan, MC, Owen, MJ, Kirov, G., Craddock, N. (2006) Variation at GRM3 influences susceptibility to psychotic bipolar disorder. Am J Hum Genet141B: 697 (abstract).
49.
Greenslad, RG, Mitchell, SN (2004) Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0] hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell. Neuropharmacology47: 1-8.
50.
Gupta, DS, McCullumsmith, GE, Beneyto, M., Haroutunian, V., Davis, KL, Meador-Woodruff, JH (2005) Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse57: 123-131.
51.
Harrison, PJ (2008) Schizophrenia genes: searching for common features, functions, and mechanisms. In: O'Donnell, P, (ed), Cortical Deficits in Schizophrenia: From Genes to Function. Norwell, MA: Springer pp1-16.
Harrison, PJ, Owen, MJ (2003) Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet361: 417- 419.
54.
Harrison, PJ, Weinberger, DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry10: 40-68.
55.
Higgins, GA, Ballard, TM, Kew, JNC, Richards, JG, Kemp, JA, Adam, G., Woltering, T., Nakanishi, S., Mutel, V. (2004) Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology46: 907-917.
56.
Homayoun, L., Jackson, ME, Moghaddam, B. (2005) Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J Neurophysiol93: 1989-2001.
57.
Jackson, PF, Slusher, BS (2001) Design of NAALADase inhibitors: a novel neuroprotective strategy. Curr Med Chem8: 949-957.
58.
Javitt, DC (2004) Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry9: 984-997.
59.
Javitt, DC, Zukin, SR (1991) Recent advances in the phencyclidine model of schizophrenia . Am J Psychiatry148: 1301-1308.
60.
Johnson, MP, Barda, D., Britton, TC, Emkey, R., Hornback, WJ, Jagdmann, GE, McKinzie, DL, Nisenbaum, ES, Tizzano, JP, Schoepp, DD (2005) Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). Psychopharmacology179: 271-283.
61.
Karasawa, J-I., Yoshimizu, T., Chaki, S. (2006) A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell. Neurosci Lett393: 127-130.
62.
Kew, JNC, Kemp, JA (2005) Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology179: 4- 29.
63.
Kew, JNC, Pflimlin, MC, Kemp, JA, Mutel, V. (2002) Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice. Neuropharmacology43: 215-221.
64.
Kohout, TA, Lefkowitz, RJ (2003) Regulation of g protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol63: 9-18.
65.
Krystal, JH, Bi-Saab, W., Perry, E., D'Souza, D., Liu, NJ, Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., Breier, A. (2005) Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology179: 303-309.
66.
Kubo, Y., Tateyama, M. (2005) Towards a view of functioning dimeric metabotropic receptors. Curr Opinion Neurobiol15: 289-295.
67.
Laurelle, M., Kegeles, LS, Abi-Dargham, A. (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann NY Acad Sci1003: 138-158.
68.
Law, AJ, Lipska, BK, Weickert, CS, Hyde, TM, Straub, RE, Hashimoto, R., Harrison, PJ, Kleinman, J.E., Weinberger, DR (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci USA103: 6747-6752.
69.
Lea, PM, Wroblewska, B., Sarvey, JM, Neale, JH (2001) Beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor. J Neurophysiol85: 1097- 1106.
70.
Linden, AM, Baez, M., Bergeron, M., Schoepp, DD (2006) Effects of mGlu2 or rnGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus . Neuropharmacology51: 213-228.
71.
Linden, AM, Shannon, H., Baez, M., Yu, JL, Koester, A., Schoepp, DD (2005) Anxiolytic-like activity of the mGlu2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice. Psychopharmacology179: 284-291.
72.
Lohmueller, KE, Pearce, CL, Pike, M., Lander, ES, Hirschhorn, JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet33: 177-182.
73.
Lorrain, DS, Schaffhauser, H., Campbell, UC, Baccei, CS, Correa, LD, Rowe, B., Rodriguez, DE, Anderson, JJ, Varney, MA, Pinkerton, AB, Vernier, JM, Bristow, LJ (2003) Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge. Neuropsychopharmacology28: 1622-1632.
74.
Lovinger, DM, McCool, BA (1995) Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGluR2 or 3. J Neurophysiol73: 1076-1083.
75.
Lujan, R., Roberts, JDB, Shigemoto, R., Ohishi, H., Somogyi, P. (1997) Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites. J Chem Neuroanat13: 219-241.
76.
Luyt, K., Varadi, A., Halfpenny, CA, Scolding, NJ, Molnar, E. (2004) Metabotropic glutamate receptors are expressed in adult human glial progenitor cells. Biochem Biophys Res Comm319: 120-129.
77.
Lyon, L., Harrison, PJ, Corti, C., Burnet, P. (2006) Altered expression of glutamate receptors and transporters in metabotropic glutamate receptor 3 (mGluR3; GRM3) knockout mice. J Psychopharmacol20: A17-A17.
78.
Lyon, L., Kew, J., Corti, C., Harrison, PJ, Burnet, PWJ (2008) Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice. Synapse (in press).
79.
Makoff, A., Volpe, F., Lelchuk, R., Harrington, K., Emson, P. (1996) Molecular characterization and localization of human metabotropic glutamate receptor type 3. Mol Brain Res40: 55-63.
80.
Malherbe, P., Richards, JG, Broger, C., Zenner, MT, Messer, J., Kratzeisen, C., Nakanishi, S., Mutel, V. (2005) Opposite effects of Zn on the in vitro binding of [H-3]LY354740 to recombinant and native metabotropic glutamate 2 and 3 receptors. J Neurochem94: 150-160.
81.
Marek, GJ, Wright, RA, Schoepp, DD, Monn, JA, Aghajanian, GK (2000) Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther292: 76-87.
82.
Marenco, S., Steele, SU, Egan, MF, Goldberg, TE, Straub, RE, Sharrief, AZ, Weinberger, DR (2006) Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. Am J Psychiatry163: 740-742.
83.
Marino, MJ, Conn, PJ (2002) Direct and indirect modulation of the N-methyl D-aspartate receptor: potential for the development of novel antipsychotic therapies. Curr Drug Targets-CNS Neurol Disord1: 1-16.
84.
Markou, A. (2007) Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression? Biol Psychiatry61: 17-22.
85.
Marti, SB, Cichon, S., Propping, P., Nothen, M. (2002) Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. Am J Med Genet114: 46-50.
86.
Matrisciano, F., Panaccione, I., Zusso, M., Giusti, P., Tatarelli, R., Iacovelli, L., Mathe, AA, Gruber, SH M, Nicoletti, F., Girardi, P. (2007) Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?Mol Psychiatry12: 704-706.
87.
Meador-Woodruff, JH, Healy, DJ (2000) Glutamate receptor expression in schizophrenic brain. Brain Res Rev31: 288-294.
88.
Melendez, RI, Gregory, ML, Bardo, MT, Kalivas, PW (2004) Impoverished rearing environment alters metabotrophic glutamate receptor expression and function in the prefrontal cortex. Neuropsychopharmacology29: 1980-1987.
89.
Milligan, G. (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol66: 1-7.
90.
Minneman, KP (2007) Heterodimerization and surface localization of G protein coupled receptors. Biochem Pharmacol73: 1043-1050.
91.
Moghaddam, B. (2003) Bringing order to the glutamate chaos in schizophrenia . Neuron40: 881-884.
92.
Moghaddam, B. (2004) Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology174: 39-44.
93.
Moghaddam, B., Adams, BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science281: 1349-1352.
94.
Morishima, Y., Miyakawa, T., Furuyashiki, T., Tanaka, Y., Mizuma, H., Nakanishi, S. (2005) Ehnhanced cociane responsiveness and impaired motor coordinatrion in metabortropic glutamate receptor subtype 2 knockout mice . Proc Natl Acad Sci USA102: 4170- 4175.
95.
Mudo, G., Trovato-Salinaro, A., Caniglia, G., Cheng, QZ, Condorelli, DF (2007) Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain. Brain Res1149: 1-13.
96.
Neki, A., Ohishi, H., Kaneko, T., Shigemoto, R., Nakanishi, S., Mizuno, N. (1996) Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neurosci Lett202: 197-200.
97.
Nicodemus, KK, Kolachana, BS, Vakkalanka, R., Straub, RE, Giegling, I., Egan, M., Rujescu, D., Weinberger, DR (2007) Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet120: 889- 906.
98.
Nicoletti, F., Arcella, A., Iacovelli, L., Battaglia, G., Giangaspero, F., Melchiorri, D. (2007) Metabotropic glutamate receptors: new targets for the control of tumor growth? Trends Pharmacol Sci28: 206-213.
99.
Norton, N., Williams, HJ, Dwyer, S., Ivanov, D., Preece, AC, Gerrish, A., Williams, NM, Yerassimou, P., Zammit, S., O'Donovan, MC, Owen, MJ (2005) No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry5: 23.
100.
Ohishi, H., Neki, A., Mizuno, N. (1998) Distribution of a metabotropic glutatnate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody. Neurosci Res30: 65-82.
101.
Ohishi, H., Ogawa-Meguro, R., Shigemoto, R., Kaneko, T., Nakanishi, S., Mizuno, N. (1994) Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex. Neuron13: 55-66.
102.
Ohishi, H., Shigemoto, R., Nakanishi, S., Mizuno, N. (1993) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol335: 252-266.
103.
Ohnuma, T., Augood, SJ, Arai, H., McKenna, PJ, Emson, PC (1998) Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Mol Brain Res56: 207-217.
104.
Olney, JW, Farber, NB (1995) Glutamate receptor dysfunction and schizophrenia . Arch Gen Psychiatry52: 998-1007.
105.
Olszewski, RT, Bukhari, N., Zhou, J., Kozikowski, AP, Wroblewski, JT, Shamimi-Noori, S., Wroblewska, B., Bzdega, T., Vicini, S., Barton, FB, Neale, JH (2004) NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR . J Neurochem89: 876-885.
106.
Olszewski, RT, Wegorzewska, MM, Monteiro, AC, Krolikowski, KA, Zhou, J., Kozikowski, AP, Long, K., Mastropaolo, J., Deutsch, SI, Neale, JH (2008) Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors. Biol Psychiatry63: 86-91.
107.
Patil, ST, Zhang, L., Martenyi, F., Lowe, SI, Jackson, KA, Andreev, BV, Avedisova, AS, Bardenstein, LM, Gurovich, IY, Morozova, MA, Mosolov, SN, Neznanov, NG, Reznik, AM, Smulevich, AB, Tochilov, VA, Johnson, BG, Monn, JA, Schoepp, DD (2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med13: 1102-1107.
108.
Petralia, RS, Wang, YX, Niedzielski, AS, Wenthold, RJ (1996) The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience71: 949-976.
109.
Poschel, B., Wroblewska, B., Heinemann, U., Manahan-Vaughan, D. (2005) The metabotropic glutamate receptor mGluR3 is critically required for hippocampal long-term depression and modulates long-term potentiation in the dentate gyrus of freely moving rats. Cereb Cortex15: 1414-1423.
110.
Prinster, SC, Hague, C., Hall, RA (2005) Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol Rev57: 289-298.
Rorick-Kehn, LM, Johnson, BG, Burkey, JL, Wright, RA, Calligaro, DO, Marek, GJ, Nisenbaum, ES, Catlow, JT, Kingston, AE, Giera, DD, Herin, MF, Monn, JA, McKinzie, DL, Schoepp, DD (2007b) Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxyli c acid (LY404039). J Pharmacol Exp Therap321: 308-317.
113.
Rorick-Kehn, LM, Johnson, BG, Knitowski, KM, Salhoff, CR, Witkin, JM, Perry, KW, Griffey, KI, Tizzano, JP, Monn, JA, McKinzie, DL, Schoepp, DD (2007a) In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders. Psychopharmacology193: 121-136.
114.
Rothstein, JD, Dykes-Hoberg, M., Pardo, CA, Bristol, LA, Jin, L., Kuncl, RW, Kanai, Y., Hediger, MA, Wang, YF, Schielke, JP, Welty, DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate . Neuron16: 675-686.
115.
Sartorius, LJ, Weinberger, DR, Hyde, TM, Harrison, PJ, Kleinman, JE, Lipska, BK (2008) Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP. Neuropsychopharmacology. doi: 10.1038/sj.npp.1301669.
116.
Sartorius, LJ, Nagappan, G., Lipska, BK, Lu, B., Sei, Y., Ren-Patterson, R., Li, Z., Weinberger, DR, Harrison, PJ (2006) Alternative splicing of human metabotropic glutamate receptor 3. J Neurochem96: 1139-1148.
117.
Scherer, SW, Duvoisin, RM, Kuhn, R., Heng, HHQ, Belloni, E., Tsui, LC (1996) Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. Genomics31: 230-233.
118.
Schoepp, DD (2001) Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther299: 12-20.
119.
Schoepp, DD, Johnson, BG, Monn, JA (1992) Inhibition of cyclic AMP formation by a selective metabotropic glutamate receptor agonist. J Neurochem58: 1184-1186.
120.
Schools, GP, Kimelberg, HK (1999) mGluR3 and mGluR5 are the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats. J Neurosci Res58: 533-543.
121.
Schwab, S., Plummer, C., Doyle, A., Albus, M., Borrmann-Hassenbach, M., Maier, W., Wildenauer, D. (2006) Association with schizophrenia in three candidate genes: GRM-3, AKT-1 and NRG-1. Am J Med Genet141B: 718-719.
122.
Schwarz, DA, Barry, G., Eliasof, SD, Petroski, RE, Conlon, PJ, Maki, RA (2000) Characterization of gamma-aminobutyric acid receptor GABA(B(1e)), a GABA(B(1)) splice variant encoding a truncated receptor. J Biol Chem275: 32174-32181.
123.
Seamans, JK, Yang, CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol74: 1-57.
124.
Selkirk, JV, Challiss, RAJ, Rhodes, A., McIlhinney, RAJ (2002) Characterization of an N-terminal secreted domain of the type-1 human metabotropic glutamate receptor produced by a mammalian cell line. J Neurochem80: 346-353.
125.
Simonyi, A., Ngomba, RT, Storto, M., Catania, MV, Miller, LA, Youngs, B., Giorgi-Gerevini, V., Nicoletti, F., Sun, GY (2005) Expression of groups I and II metabotropic glutamate receptors in the rat brain during aging. Brain Res1043: 95-106.
126.
Spinelli, S., Ballard, T., Gatti-McArthur, S., Richards, GJ, Kapps, M., Woltering, T., Wichmann, J., Stadler, H., Feldon, J., Pryce, CR (2005) Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys. Psychopharmacology179: 292-302.
127.
Spooren, W., Ballard, T., Gasparini, F., Amalric, M., Mutel, V., Schreiber, R. (2003) Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol14: 257-277.
128.
Spooren, Wpjm, Gasparini, F., van der Putten, H., Koller, M., Nakanishi, S., Kuhn, R. (2000) Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice. Euro J Pharmacol397: R1-R2.
129.
Stone, JM, Morrison, PD, Pilowsky, LS (2007) Review: glutamate and dopamine dysregulation in schizophrenia a synthesis and selective review. J Psychopharmacol21: 440-452.
Swanson, CJ, Bures, M., Johnson, MP, Linden, AM, Monn, JA, Schoepp, DD (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nature Rev Drug Discovery4: 131-134.
132.
Swanson, CJ, Perry, KW, Schoepp, DD (2004) The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex. J Neurochem88: 194-202.
133.
Tamaru, Y., Nomura, S., Mizuno, N., Shigemoto, R. (2001) Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience106: 481-503.
134.
Tamminga, CA (1998) Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol12: 21-36.
135.
Tan, H-Y., Chen, Q., Sust, S., Buckholtz, JW, Meyers, JD, Egan, M., Mattay, VS, Meyer-Lindenberg, A., Weinberger, DR, Callicott, JH (2007a) Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci USA104: 12536-12541.
136.
Tan, W., Wang, Y., Gold, B., Chen, J., Dean, M., Harrison, PJ, Weinberger, DR, Law, AJ (2007b) Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem282: 24343-24351.
137.
Tanabe, Y., Masu, M., Ishii, T., Shigemoto, R., Nakanishi, S. (1992) A family of metabotropic glutamate receptors. Neuron8: 169-179.
138.
Tanabe, Y., Nomura, A., Masu, M., Shigemoto, R., Mizuno, N., Nakanishi, S. (1993) Signal transduction, pharmacological properties, and expression patterns of 2 rat metabotropic glutamate receptors, mGlur3 and mGlur4. J Neurosci13: 1372-1378.
139.
Tang, FR, Lee, WL (2001) Expression of the group II and III metabotropic glutamate receptors in the hippocampus of patients with mesial temporal lobe epilepsy. J Neurocytol30: 137-143.
140.
Tascedda, F., Blom, JMC, Brunello, N., Zolin, K., Gennarelli, M., Colzi, A., Bravi, D., Carra, S., Racagni, G., Riva, MA (2001) Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. Biol Psychiatry50: 117-122.
141.
Testa, CM, Standaert, DG, Young, AB, Penny, JB (1994) Metabotropic glutamate receptor messenger RNA expression in the basal ganglia of the rat. J Neurosci14: 3005-3018.
142.
Tochigi, M., Suga, M., Ohashi, J., Otowa, T., Yamasue, H., Kasai, K., Kato, T., Okazaki, Y., Kato, N., Sasaki, T. (2006) No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population. Schizophr Res88: 260-264.
143.
Tsai, G., Coyle, JT (2002) Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol42: 165-179.
144.
Tsai, G., Passani, LA, Slusher, BS, Carter, R., Baer, L., Kleinman, JE, Coyle, JT (1995) Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry52: 829-836.
145.
Tunbridge, EM, Harrison, PJ, Weinberger, DR (2006) Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry60: 141-151.
146.
van Berckel, BNM, Kegeles, LS, Waterhouse, R., Guo, NN, Hwang, DR, Huang, YY, Narendran, R., Van Heertum, R., Laruelle, M. (2006) Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography. Neuropsychopharmacology31: 967-977.
147.
Villemure, JF, Adam, L., Bevan, NJ, Gearing, K., Chenier, S., Bouvier, M. (2005) Subcellular distribution of GABA(B) receptor homo- and hetero-dimers. Biochem J388: 47-55.
148.
Weinberger, DR (2007) Schizophrenia drugs say goodbye to dopamine. Nat Med13: 1018-1019.
149.
Winder, DG, Conn, PJ (1996) Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication. J Neurosci Res46: 131-137.
150.
Winterer, G., Weinberger, DR (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci27: 683- 690.
151.
Wroblewska, B., Wegorzewska, IN, Bzdega, T., Olszewski, RT, Neale, JH (2006) Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes. J Neurochem96: 1071-1077.
152.
Wroblewska, B., Wroblewski, JT, Pshenichkin, S., Surin, A., Sullivan, SE, Neale, JH (1997) N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem69: 174-181.
153.
Yao, Y., Koo, JCP, Wells, JW, Hampson, DR (2004) Expression of a truncated secreted form of the mGluR3 subtype of metabotropic glutamate receptor. Biochem Biophys Res Comm319: 622-628.
154.
Yokoi, M., Kobayashi, K., Manabe, T., Takahashi, T., Sakaguchi, I., Katsuura, G., Shigemoto, R., Ohishi, H., Nomura, S., Nakamura, K., Nakao, K., Katsuki, M., Nakanishi, S. (1996) Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science273: 645-647.
155.
Yourick, DL, Koenig, ML, Durden, AV, Long, JB (2003) N-acetylaspartylglutamate and beta-NAAG protect against injury induced by NMDA and hypoxia in primary spinal cord cultures . Brain Res991: 56-64.
156.
Zhao, J., Ramadan, E., Cappiello, M., Wroblewska, B., Bzdega, T., Neale, JH (2001) NAAG inhibits KCl-induced [H-3]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance. Eur J Neurosci13: 340-346.
